Skip to main content
Elsevier

Cutting-Edge Nanocarrier-Based Strategies in the Management of Leukaemia

  • 1st Edition - February 17, 2026
  • Latest edition
  • Editors: Devesh U. Kapoor, Bhupendra G. Prajapati, Anand Krishnan
  • Language: English

Cutting-edge Nanocarrier-Based Strategies in the Management of Leukaemia addresses the importance of nanocarriers in leukemia treatment. The book explores advancements in nanote… Read more

Description

Cutting-edge Nanocarrier-Based Strategies in the Management of Leukaemia addresses the importance of nanocarriers in leukemia treatment. The book explores advancements in nanotechnology, highlighting therapies like siRNA, miRNA, and gene therapy that improve patient outcomes. Sections provide an introduction to leukemia, covering its epidemiology and risk factors, discuss innovative therapies and the use of various nanocarriers, such as polymeric nanoparticles, liposomes, dendrimers, and hydrogels, and discuss precision medicine, AI in leukemia care, and strategies to overcome treatment resistance. The book is enriched with tables, figures, and images, giving healthcare providers, including physicians, immunologists, oncologists, and pharmacists an invaluable resource on cutting-edge therapies.

Key features

  • Provides an in-depth exploration of various nanocarrier-based therapies for leukemia
  • Integrates perspectives from multiple fields, such as nanotechnology, artificial intelligence, and personalized medicine
  • Enhances comprehension and provides practical insights, helping readers better understand and apply the discussed therapies in clinical settings

Readership

Researchers, clinicians, and healthcare providers specializing in oncology, hematology, nanotechnology, and personalized medicine.

Table of contents

1. Introduction

2. siRNA and miRNA therapies for leukaemia

3. Gene therapy for leukaemia

4. Exploring Polymeric nanoparticles in leukaemia management

5. Magnetic Nanoparticles in Leukemia Therapy: Advancements and Future Directions

6. Mesoporous Silica Nanoparticles: A Novel Approach in Targeted Leukemia Therapy

7. Targeted Leukemia Therapy with Solid Lipid Nanoparticles: Potential and Progress

8. The Role of Exosomes in Leukemia Treatment: Advancements in Biomarker Discovery and Drug Delivery

9. Nanoemulsion-Based Drug Delivery in Leukemia: Potential and Progress in Therapeutic Applications

10. Advances in Leukemia Treatment using Micelles and Dendrimers

11. Revolutionizing Leukemia Therapy with Liposomes and Niosomes: Targeted Delivery and Improved Efficacy

12. Biological and immunological aspects of nanocarriers and nano-vaccines

13. Leveraging AI and machine learning for prostate cancer management 14. Role of DNA Origami and mRNA/siRNA nanocarriers in prostate cancer

Product details

  • Edition: 1
  • Latest edition
  • Published: February 17, 2026
  • Language: English

About the editors

DK

Devesh U. Kapoor

Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. His academic and research expertise centers on pharmaceutics, nanodrug delivery, and modified‑release drug delivery systems. Dr. Kapoor has made extensive scholarly contributions through research and review publications, book chapters, and edited volumes with international publishers. He is actively involved in postgraduate and doctoral research supervision in advanced drug delivery technologies. His editorial experience includes serving in senior editorial roles for international journals across pharmacology, pharmaceutics, and biomedical sciences, along with regular peer‑review activity for a wide range of scientific journals. Dr. Kapoor has also secured competitive research and academic development funding and is a frequent invited speaker at national scientific meetings, workshops, and academic programs.

Affiliations and expertise
Professor, Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, India

BP

Bhupendra G. Prajapati

Dr. Bhupendra Gopalbhai Prajapati is Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India, and serves as Adjunct Professor in the Department of Industrial Pharmacy at Silpakorn University, Thailand. His academic, research, and industry expertise focuses on lipid‑based formulations, nano‑ and microparticulate drug delivery systems, and strategies to enhance drug bioavailability. Dr. Prajapati has received several academic and professional honors recognizing excellence in teaching and research. He has made substantial scholarly contributions through research and review publications, book chapters, and edited volumes in pharmaceutical sciences. Actively engaged in postgraduate and doctoral mentoring, he supports research training in advanced drug delivery and formulation science. Dr. Prajapati also serves in editorial and section‑editor roles for international scientific publications, contributing to the advancement and quality of pharmaceutical research dissemination.

Affiliations and expertise
Parul Institute of Pharmacy, Faculty of Pharmacy, Parul University, Waghodia, Vadodara, Gujarat, India

AK

Anand Krishnan

Dr. Anand Krishnan, Principal Investigator in Chemical Pathology, Office of the Dean, Faculty of Health Sciences, University of the Free State, South Africa. He leads the Precision Medicine Integrative Nano Diagnostics (P-MIND) laboratories, which focus on the biological functions of extracellular vesicles (EVs) in synthetic biology. His research encompasses cell surface protein modification, biomarker discovery through EVs derived from liquid biopsies, and the role of circulating biomarkers in disease development and stem cell biology. Dr. Krishnan has authored over 150 articles and edited eight books published by Elsevier, Springer, and Wiley. He received the National Research Foundation (NRF) rating for Next Generation Researchers in South Africa. In the latest list published by Stanford University, Dr. Krishnan was named among the Top 2% of the most influential scientists worldwide. He is an active member of the International Society of Extracellular Vesicles (ISEV), the African Organisation for Research and Training in Cancer (AORTIC), and the American Association of Cancer Research (AACR). Recently, he has been serving as an editor for the eLife journal, focusing on the Africa region.

Affiliations and expertise
Precision Medicine and Integrated Nano-Diagnostics (P-MIND) Research Group, Office of the Dean, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa

View book on ScienceDirect

Read Cutting-Edge Nanocarrier-Based Strategies in the Management of Leukaemia on ScienceDirect